Serum/plasma cancer antigen 19-9 (CA 19-9) concentration
This test measures the amount of a protein called cancer antigen 19-9 in your blood. It may help detect or monitor certain cancers, including pancreatic cancer.
["CA 19-9 can help track cancer progression or response to treatment."]
Key facts at a glance
- LOINC
- 24108-3
- Short code
- CA19-9
- Synonyms
- Cancer Ag19-9 SerPl-aCnc
- Category
- chemistry
- Sample
- serum
- Container
- SST (Serum Separator Tube) or Red-top tube; also acceptable in lithium-heparin plasma tube
- Units
- N/A
- Ref low
- 0
- Ref high
- 37
- Critical range
- 0.5 N/A – 1000 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Immunoassay (Electrochemiluminescence or Chemiluminescent)
- CPT
- 86301
- SNOMED
- 1152690006
- Specimen volume
- 1 mL serum or plasma
- Stability
- Room temperature: 8 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): 3 months; Avoid repeated freeze-thaw cycles
- Hemolysis max
- 100
- Lipemia max
- 500
- Icterus max
- 30
- TAT
- 4–24 hours
- Order
- routine
What Is CA 19-9 Used For?
CA 19-9 is primarily used as a biomarker for pancreatic cancer screening and monitoring. It may also be checked in other cancers, such as stomach, bile duct, or gallbladder cancers, though less commonly. Doctors may order this test if you have symptoms like abdominal pain, unexplained weight loss, or a known risk for these cancers.
How Is the Test Performed?
A blood sample is taken from a vein in your arm. The blood is sent to a lab where it is analyzed for the presence of CA 19-9 protein using immunoassay techniques. This process helps determine the concentration of the protein in your blood.
What Does a High or Low Level Mean?
High levels of CA 19-9 can indicate pancreatic cancer or other cancers mentioned above. However, elevated levels can also occur in non-cancerous conditions, such as chronic pancreatitis or liver disease. Low levels typically suggest no cancer is present, but they don’t rule out other conditions.
When Might You Need This Test?
Your doctor may recommend a CA 19-9 test if you have symptoms related to cancer, a known history of cancer, or if you are undergoing treatment for a cancer that may produce CA 19-9. It may also be used as part of follow-up care to monitor the progression or effectiveness of treatment.
Reference range
Normal: <37 U/mL; Values >37 U/mL may indicate malignancy or benign conditionsN/A
No fasting required. Specimen should be collected prior to administration of biotin-containing supplements or medications when possible, as high biotin levels may interfere with immunoassay results.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance: CA 19-9 is a tumor marker that can assist in diagnosing, staging, and monitoring pancreatic cancer. While it is not a definitive test on its own, it can provide important information alongside other diagnostic tests, such as imaging studies. It is important to discuss results with your healthcare provider, as they will consider the full clinical picture when interpreting your test results.
Short name
CA 19-9 blood test
Frequently asked questions
Why might my CA 19-9 test be ordered?
Can CA 19-9 levels be affected by other health conditions?
What should I do if my CA 19-9 test results are abnormal?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy